CONCERT: A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-Blind Twelve-Month Safety and Efficacy Study evaluating Dimebon in Patients with Mild-to-moderate Alzheimer Disease on Donepezil (2009–2011)

Grant type:
Novotech (Australia) Pty Ltd
Researchers:
  • Professor
    Royal Brisbane Clinical Unit
    Faculty of Medicine
    Affiliate Professor
    UQ Centre for Clinical Research
    Faculty of Medicine
Funded by:
Novotech (Australia) Pty Ltd